Latest FocusMaking better tablets: A QbD approach (Free)In this article, the authors describe how a benchtop tablet press and material tester characterizes both tablets and materials to help you develop a robust formulation. It also touches on the shortcomings of the FDA’s SUPAC guidances in improving existing tablet formulations.Continuous tablet manufacturing: Faster development and greater efficiencyCommercial pressure to shorten development times, improve the efficiency of drug development, and reduce the amount of API required is driving a trend toward continuous processing. At the same time, regulators are encouraging manufacturers to establish processes that incorporate the FDA’s Quality by Design (QbD) and Process Analytical Technology (PAT) initiatives. This article describes the benefits of continuous tablet manufacturing.I Holland’s TSAR-Predict forecasts faster fixes for sticking problemsPredictive model enables company to identify best punch or die coating for sticky formulations.General FeaturesHard work on softgels pays off at Forever LivingCompany brings manufacturing in-house to ensure quality, boost yields.Eye on Excipients: On-site audits of suppliersDevelop an annotated checklist before you conduct on-site audits of excipient suppliers. That upfront work will help you better assess the quality and safety of the supplier’s products. It may even eliminate the need for a site visit.
Back Page: How’s your deduster?(Free)If dust is accumulating or reaching downstream areas, it’s time for a checkup.